
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£189.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£122.34
7D
1.5%
1Y
3.0%
Chugai Pharmaceutical
Market Cap: JP¥11.6t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,051.00
7D
2.4%
1Y
10.5%
Orion Oyj
Market Cap: €11.3b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€80.10
7D
1.3%
1Y
15.1%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥50.4b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥112.09
7D
-3.8%
1Y
0.7%
Xiamen Amoytop Biotech
Market Cap: CN¥24.5b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥60.00
7D
-6.8%
1Y
-27.2%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.1b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€60.80
7D
1.8%
1Y
5.7%
PharmaResearch
Market Cap: ₩4.6t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩442,000.00
7D
13.0%
1Y
-37.2%